0001209191-21-033810.txt : 20210518 0001209191-21-033810.hdr.sgml : 20210518 20210518201558 ACCESSION NUMBER: 0001209191-21-033810 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210518 FILED AS OF DATE: 20210518 DATE AS OF CHANGE: 20210518 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SEIDENBERG BETH C CENTRAL INDEX KEY: 0001184592 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40407 FILM NUMBER: 21938037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vera Therapeutics, Inc. CENTRAL INDEX KEY: 0001831828 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 812744449 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 170 HARBOR WAY STREET 2: 3RD FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-770-0077 MAIL ADDRESS: STREET 1: 170 HARBOR WAY STREET 2: 3RD FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-05-18 0 0001831828 Vera Therapeutics, Inc. VERA 0001184592 SEIDENBERG BETH C C/O VERA THERAPEUTICS, INC. 170 HARBOR WAY, 3RD FLOOR SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Class A Common Stock 2021-05-18 4 C 0 423642 A 423642 I See footnote Class A Common Stock 2021-05-18 4 C 0 100526 A 524168 I See footnote Class A Common Stock 2021-05-18 4 C 0 818984 A 1343152 I See footnote Series A Preferred Stock 2021-05-18 4 C 0 423642 0.00 D Class A Common Stock 423642 0 I See footnote Series B Preferred Stock 2021-05-18 4 C 0 100526 0.00 D Class A Common Stock 100526 0 I See footnote Series C Preferred Stock 2021-05-18 4 C 0 818984 0.00 D Class A Common Stock 818984 0 I See footnote The Series A Preferred Stock automatically converted into Class A Common Stock on a 11.5869:1 basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on May 7, 2021) and had no expiration date. Consists of 409,620 shares of Class A Common Stock held by Kleiner Perkins Caufield & Byers XVI, LLC ("KPCB XVI") and 14,022 shares of Class A Common Stock held by KPCB XVI Founders Fund, LLC ("XVI Founders"). All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee". The managing member of KPCB XVI is KPCB XVI Associates, LLC ("XVI Associates"). L. John Doerr, Beth Seidenberg, Randy Komisar, Theodore E. Schlein and Wen Hsieh, the managing members of KPCB XVI Associates, exercise shared voting and dispositive control over the shares held by KPCB XVI. Such managing members disclaim beneficial ownership of all shares held by KPCB XVI except to the extent of their pecuniary interest therein. The Series B Preferred Stock automatically converted into Class A Common Stock on a 11.5869:1 basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on May 7, 2021) and had no expiration date. Consists of 506,819 shares of Class A Common Stock held by KPCB XVI and 17,349 shares of Class A Common Stock held by XVI Founders. All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee". The managing member of KPCB XVI is XVI Associates. L. John Doerr, Beth Seidenberg, Randy Komisar, Theodore E. Schlein and Wen Hsieh, the managing members of KPCB XVI Associates, exercise shared voting and dispositive control over the shares held by KPCB XVI. Such managing members disclaim beneficial ownership of all shares held by KPCB XVI except to the extent of their pecuniary interest therein. The Series C Preferred Stock automatically converted into Class A Common Stock on a 11.5869:1 basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on May 7, 2021) and had no expiration date. Consists of 1,298,695 shares of Class A Common Stock held by KPCB XVI and 44,457 shares of Class A Common Stock held by XVI Founders. All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee". The managing member of KPCB XVI is XVI Associates. L. John Doerr, Beth Seidenberg, Randy Komisar, Theodore E. Schlein and Wen Hsieh, the managing members of KPCB XVI Associates, exercise shared voting and dispositive control over the shares held by KPCB XVI. Such managing members disclaim beneficial ownership of all shares held by KPCB XVI except to the extent of their pecuniary interest therein. Consisted of 409,620 shares of Class A Common Stock that was automatically converted from the Issuer's Series A Preferred Stock held by KPCB XVI and 14,022 shares of Class A Common Stock that was automatically converted from the Issuer's Series A Preferred Stock held by XVI Founders. Consisted of 97,199 shares of Class A Common Stock that was automatically converted from the Issuer's Series B Preferred Stock held by KPCB XVI and 3,327 shares of Class A Common Stock that was automatically converted from the Issuer's Series B Preferred Stock held by XVI Founders. Consisted of 791,876 shares of Class A Common Stock that was automatically converted from the Issuer's Series C Preferred Stock held by KPCB XVI and 27,108 shares of Class A Common Stock that was automatically converted from the Issuer's Series C Preferred Stock held by XVI Founders. /s/ Joseph R. Young, Attorney-in-Fact 2021-05-18